Stanford Medicine researchers have developed an intranasal liposomal vaccine that protected mice against SARS-CoV-2, ...

A new Stanford study marks a big step forward in the creation of a new kind of vaccine that offers protection against a range ...

Scientists at Stanford Medicine have unveiled a bold new kind of “universal” vaccine that could one day protect against everything from COVID-19 and the flu to bacterial pneumonia and even common ...

Mycobacterium tuberculosis, the pathogen responsible for tuberculosis, has evolved a remarkably layered set of molecular ...

A new review by Dr. Ruyuan Wang and an international team of researchers explores the complex interactions between the innate and adaptive immune systems, shedding light on regulatory mechanisms in ...

An innovative approach supercharges the innate immune system to provide a first line of defence against respiratory ...

Adaptive Biotechnologies (“we” or “our”) is a commercial-stage biotechnology company focused on harnessing the inherent biology of the adaptive immune system to transform the diagnosis and treatment ...

In a recent perspective review, researchers attempt to collate and discuss scientific knowledge on the concept of the ‘immune self’ and use raw T cell assays, nine amino-long pathogen-derived peptides ...

Researchers engineered a strain of Listeria monocytogenes that stimulates gamma delta T cells, key innate immune fighters ...